Autoscribe Informatics Appoints Distributor for France, Italy & Switzerland
News Jun 23, 2016

John Boother, President at Autoscribe Informatics said: “Following on from our recent successes in the USA, we are also keen to expand our penetration into European markets. With three offices and a staff boasting qualified scientists from a number of disciplines, Ritme has a field-based and in-house team of native speakers that work closely with customers both before and after product purchase, which exactly mirrors our own approach. Ritme’s well-established consulting services will facilitate and drive successful LIMS projects.”
Ritme CEO, Thierry Berton, commented: “Matrix Gemini LIMS is an important extension to our scientific software portfolio allowing our customers to efficiently manage their laboratories. The flexibility of Autoscribe Informatics LIMS solution allows either Ritme, or our customers, to configure a solution that meets the exact needs of each laboratory. The configuration tools provide easy adaption of desktop and web based applications without the use of any software scripts or coding. It makes it the perfect choice for laboratories that need to adapt their LIMS as the working practices in the laboratory change. In addition, the ability to run fully tailored state-of-the-art LIMS offline is a critical selling point for many labs with high data protection policies.”
RELATED ARTICLES
The Genes That Make Quorn a Fungal Food Favorite
NewsThe meat substitute Quorn is derived from a fungus called Fusarium venenatum. A very similar fungus, F. graminearum, is one of the world's most damaging crop diseases. A new genome study shows why one fungus makes food, and the other destroys it.
READ MORENeural Computer Hears Like Humans
NewsModelling the human senses is an incredibly complex task. Our brains arrange cells into complex hierarchies that process information from our surroundings. Now, a group at MIT have created a model of the human auditory cortex that can hear sounds and music in the same way that humans do.
READ MOREStable Beta-Amyloid Dimers Identified in Alzheimer’s Brains
NewsA recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.
Comments | 0 ADD COMMENT
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREEInternational Conference on Analytical and Bio Analytical Techniques
Oct 31 - Nov 01, 2018
Login
You must be logged in to post a comment.